Defining the p63 regulatory network driving periderm development in the mouse
Defining the p63 regulatory network driving periderm development in the mouse
批准号:
BB/V011626/1
负责人:
Michael Dixon
金额:
$76.34万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
How cells transition between different cellular states is a fundamental biological question. In this context, the simple ectoderm passes through a dynamic series of cell states to produce a self-replenishing, multi-layered epidermis that protects the organism from dehydration, mechanical trauma, and microbial invasion. The first stratification event results in the formation of a layer of flattened periderm cells. Periderm development commences on the tail and limbs before spreading over the torso and face so that the embryo is covered by embryonic day (E)14; all stages of periderm development are therefore present in individual E11.5 embryos.Periderm functions as an embryonic barrier that prevents pathological adhesion between epithelia during development. Failure of periderm formation underlies several birth defects that are characterised by webbing of the skin across the major joints, cleft lip and/or palate, fusion of the fingers and/or toes, and genital malformations.While we have demonstrated that the transcription factor DeltaNp63Alpha (DNp63A) is a key regulator of periderm development, the regulatory networks controlling this fundamentally important cell layer are poorly characterised; this is a barrier to understanding a major event in epidermal development and in dissecting disease pathogenesis.We have assembled a team of investigators with expertise in developmental biology, gene regulation, and computational biology with the aim of delineating the regulatory interactions that drive cells to delaminate from the ectoderm to form periderm. Two objectives will be addressed:1. Predicting the regulatory networks driving mouse periderm formation at single-cell (sc) resolution: We will define the transcriptome of the developing periderm by performing scRNA-seq analysis of skin dissected from E11.5 wild-type mice in which all stages of periderm development are present. Clustering algorithms will be used to identify sub-populations of cells and expression of their 'marker genes' will be analysed to reconstruct the populations into a tissue context. Developmental trajectories will be inferred computationally allowing us to study the relationships of the clusters during development.To identify regulatory elements, we will perform scATAC-seq analysis and infer the interactions of transcription factors and their target genes. We will link open regulatory regions to their target genes and use the scATAC-seq data to infer potential upstream regulators through differential enrichment of transcription factor binding motifs. Evolution of the regulatory networks driving periderm development will be analysed computationally.Deliverables: We will predict the regulatory networks driving periderm development at single-cell resolution allowing us to formulate hypotheses about the DNp63A regulatory cascade.2. Dissecting the molecular cascade downstream of the transcription factor DNp63A: We will use the data generated in Objective 1 to extend the DNp63A regulatory network. We will perform scRNA-seq and scATAC-seq analyses of skin dissected from E11.5 Tp63-null mice and perform computational analyses to investigate how the predicted regulatory networks are perturbed.The inferred regulatory interactions will be verified experimentally. Direct transcriptional targets of DNp63A will be confirmed by ChIP-qPCR analysis of E11.5 skin. Subsequently, we will extend the ChIP-qPCR analyses to the second layer of network regulation. To analyse whether the transcription factors act as activators or repressors, we will perform luciferase reporter assays and deadCas9-mediated CRISPR activation/inhibition studies.Deliverables: We will validate the DNp63A regulatory network driving periderm development at single-cell resolution.The data will provide mechanistic insights into cell state transitions during development and will have potential impact in determining the pathogenesis of a series of congenital disorders.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.12688/f1000research.53926.2
发表时间:
2021
期刊:
F1000Research
影响因子:
--
作者:
[Briggs P, Hunter AL, Yang SH, Sharrocks AD, Iqbal M]
通讯作者:
Iqbal M
DOI:
10.1111/odi.14174
发表时间:
2022-07
期刊:
ORAL DISEASES
影响因子:
3.8
作者:
[Hammond, Nigel L., Dixon, Michael J.]
通讯作者:
Dixon, Michael J.
Collaborative Research: ELEMENTS: The LROSE Science Gateway LIDAR/RADAR Analysis In The Cloud
-
批准号:2103785
-
项目类别:Standard Grant
-
资助金额:$29.6万
-
财政年份:2021
-
负责人:Michael Dixon
-
依托单位:
Deciphering the role of p63 in secondary palate development using systems biology
-
批准号:MR/M012174/1
-
项目类别:Research Grant
-
资助金额:$88.56万
-
财政年份:2015
-
负责人:Michael Dixon
-
依托单位:
Dissecting the role of sonic hedgehog signalling during development of the secondary palate: a systems-level approach
-
批准号:G1001601/1
-
项目类别:Research Grant
-
资助金额:$79.03万
-
财政年份:2011
-
负责人:Michael Dixon
-
依托单位:
Prevention of cleft palate: the critical role of p63 and IRF6 signalling
-
批准号:G0901539/1
-
项目类别:Research Grant
-
资助金额:$86.11万
-
财政年份:2010
-
负责人:Michael Dixon
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Jag1/2启动子异常甲基化通过P63促进食管鳞癌免疫治疗耐药的机制研究
-
批准号:2024Y9328
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:林济红
-
依托单位:
MAGEA3与转录因子p63通过相分离互作调控细胞焦亡介导食管鳞癌化疗耐药的机制研究
-
批准号:82373035
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:饶栓
-
依托单位:
先锋转录因子p63通过重塑染色质结构调控肝内胆管癌相关基因KRT17的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:喻昕阳
-
依托单位:
p63介导的染色质重塑在氡暴露致肺癌发生中的作用及其分子机制研究
-
批准号:82103777
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘巧维
-
依托单位:
p63在食管上皮发育中的作用及调控机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:章永春
-
依托单位:
p63/circHERC4/miR-155轴调控子宫颈癌细胞铂耐药的分子机制
-
批准号:82172774
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:赵卫东
-
依托单位:
p63/YY1通过调控染色质结构激活SULF2介导肝癌的机制研究
-
批准号:32100447
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:喻昕阳
-
依托单位:
p63介导的染色质重塑在氡暴露致肺癌发生中的作用及其分子机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2021
-
负责人:刘巧维
-
依托单位:
p63与KLF4协同调控ESCs表皮分化和应用于烧伤创面愈合的研究
-
批准号:82172198
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:韩春茂
-
依托单位:
上皮转录因子p63与增强子调控鼻黏膜炎症上皮干细胞异常增殖和分化的机制研究
-
批准号:81974139
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2019
-
负责人:李春炜
-
依托单位: